People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Agriculture, Pharmaceuticals, Other Health Care, Other, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Grail, Inc. | — | Biotechnology | Growth/Late | $2.2B | $2.9B | 2019 |
| Juno Therapeutics, Inc. | — | Biotechnology | Growth/Late | $1.1B | $1.3B | 2013 |
| National Resilience, Inc. | — | Biotechnology | Growth/Late | $755.0M | $29.2B | 2020 |
| Gossamer Bio, Inc. | — | Biotechnology | Series D+ | $632.6M | $3.2B | 2018 |
| Neumora Therapeutics, Inc. | — | Biotechnology | Growth/Late | $474.4M | $19.0B | 2020 |
| Vir Biotechnology, Inc. | — | Biotechnology | Series D+ | $348.4M | $1.3B | 2018 |
| Syros Pharmaceuticals, Inc. | — | Biotechnology | Series D+ | $296.1M | $2.6B | 2018 |
| Fate Therapeutics Inc | — | Biotechnology | Series C | $241.3M | $2.0B | 2013 |
| High Plains Partners, LLC | — | Agriculture | Series D+ | $230.0M | $2.0B | 2022 |
| Beam Therapeutics Inc. | — | Pharmaceuticals | Series D+ | $218.6M | $4.8B | 2018 |
| Unity Biotechnology, Inc. | — | Biotechnology | Series D+ | $208.6M | $2.3B | 2009 |
| Nutcracker Therapeutics, Inc. | — | Biotechnology | Series D+ | $172.5M | $4.1B | 2020 |
| Insitro, Inc. | — | Biotechnology | Series D+ | $143.2M | $5.9B | 2020 |
| Faraday Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $115.5M | $829.7M | 2014 |
| Agios Pharmaceuticals Inc | — | Pharmaceuticals | Series C | $86.8M | $2.7B | 2010 |
| Kythera Biopharmaceuticals Inc | — | Pharmaceuticals | Series B | $37.4M | $1.3B | 2011 |
| Arivale Inc. | — | Other Health Care | Series B | $30.6M | $301.3M | 2017 |
| Receptos, Inc. (f.k.a. Receptor Pharmaceuticals Inc.) | — | Pharmaceuticals | Series A | $30.5M | $334.7M | 2009 |
| Apex Neuro Holdings, Inc. | — | Other | Series B | $24.0M | $43.8M | 2019 |
| RIPPL Care, Inc. | — | Healthtech | Series B | $23.0M | $143.8M | 2024 |
| Medical Creations, Inc. | — | Healthtech | Series A | $17.9M | $122.4M | 2021 |
| Kilimanjaro Energy, Inc. | — | Other Technology | Seed | $3.1M | $76.7M | 2010 |
Robert Nelsen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Nelsen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kristina Burow | 7 | 16 |
| Amir Nashat | 3 | 14 |
| Richard Klausner | 3 | 7 |
| William Rastetter | 3 | 4 |
| Nathaniel David | 3 | 3 |
| Robert Nelson | 2 | 7 |
| Vicki Sato | 2 | 6 |
| Doug Cole | 2 | 6 |
| PAUL Grayson | 2 | 5 |
| Faheem Hasnain | 2 | 5 |
| Robert T. Nelsen | 2 | 5 |
| Michael Yi | 2 | 4 |
| Hans Bishop | 2 | 3 |
| Robert E. Nelsen | 2 | 3 |
| Francois Kress | 2 | 3 |
| MAYKIN HO | 2 | 2 |
| William T. Rastetter | 2 | 2 |
| Philip Sharp | 2 | 2 |
| Steven Gillis | 1 | 23 |
| Bryan Roberts | 1 | 18 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.